SCHEMBL9941022

SCHEMBL9941022

O=C(NC(Cc1ccc(-c2cc(Cl)ccc2F)cc1)C[C@@H](O)C(=O)O)c1nn(-c2ccccc2)c(=O)[nH]1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930207 1.00 MME (0.59) MME
SCHEMBL18837931 0.93 MME (0.69) MME
SCHEMBL16975179 0.93 MME (0.69) MME
SCHEMBL9930524 0.87 MME (0.77) MME
SCHEMBL18724775 0.87 MME (0.77) MME
SCHEMBL16975194 0.87 MME (0.67) MME
SCHEMBL16930682 0.87 MME (0.67) MME
SCHEMBL9929562 0.84 MME (0.73) MME
SCHEMBL9929968 0.84 MME (0.68) MME
SCHEMBL9941377 0.84 MME (0.68) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 — — EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 — — WO disclosed
Send feedback